Abstract Details
|
J. Kent Werner, Jr., MD, PhD
(Uniformed Services University)
PRESENTER |
Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics. |
| Christa O'hana S. Nobleza, MD | Dr. Nobleza has nothing to disclose. |
| No disclosure on file | |
| Rebecca F. Gottesman, MD, PhD (Johns Hopkins University) | The institution of Dr. Gottesman has received research support from NIH. |
| Wendy C. Ziai, MD (Johns Hopkins Univ, Neuro Critical Care) | Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ziai has received research support from NIH. Dr. Ziai has received publishing royalties from a publication relating to health care. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant with DOJ. |
| Ulf Ziemann, MD (HMCS, NINDS, NIH) | No disclosure on file |